co-financing

1.

Global Fund Board approves new country and multi-country grants valued at $47.3 million

20 Aug 2019
Interventions from the UQD Register worth $42.2 million also approved

On 16 August 2019, by electronic vote, the Global Fund Board approved funding for three country grants worth $32.7 million (Colombia HIV, Honduras TB/HIV and Kazakhstan TB). Domestic commitments for the programs included in the approved country grants amounted to $1.17 billion. Initiatives valued at $2.4 million were added to the Unfunded Quality Demand (UQD) Register. (See Table 1.)

4.

Global Fund programs grapple with challenging monetary environment in Zimbabwe

26 Jun 2019
Global Fund grants struggle in context of de-dollarization reforms
1.

Global Fund Board approves new country and multi-country grants along with interventions on UQD Register

27 May 2019
Largest single award was $13.2 million for a Burkina Faso malaria grant

On 13 May 2019, the Global Fund Board approved, by electronic vote, funding for five country grants having a total value of $25.2 million. Domestic commitments for the programs included in the approved country grants amounted to $937.9 million. The five country grants were for four countries: Gabon, Georgia, Peru and Serbia. The largest award ($9.3 million) was for a Georgia HIV grant. (See Table 1 for details.)

7.

Malawi faces wide-ranging challenges in Global Fund grant implementation

19 Mar 2019
Some relate to Global Fund processes, others to political and economic context
4.

India Health Fund provides platform for domestic financing and innovation to combat TB and malaria

19 Mar 2019
The collaborative initiative, seeded by Tata Trusts, comes to the co-financing table

With an acute need to increase health budgets, innovative financing, especially mobilized within nations, is increasingly in the spotlight.

5.

New implementation arrangements for the Global Fund’s TB grants to Nigeria

28 Jan 2019
Transition to the new arrangements will happen in the first six months of 2019

New implementation arrangements have been put in place for the TB programs funded through Nigeria’s new TB and TB/HIV grants.

6.

The Global Fund seeks the right balance between risk mitigation and grant implementation in Mali malaria grant

28 Jan 2019
Because of Mali’s extreme malaria burden, its grant portfolio has been designated “high impact”

When it recommended a Mali malaria grant for approval recently, the Global Fund’s Grant Approvals Committee (GAC) acknowledged that there are implementation challenges associated with this grant and said that it welcomed the Secretariat’s plans “to identify bottlenecks, and holistically review and harmonize the controls in place with the aim of balancing risk mitigation and effective grant implementation.”

7.

Three countries, three different applications of co-financing in Global Fund grants in sub-Saharan Africa

16 Jan 2019
Inconsistent application of co-financing policy across countries

One of the Global Fund’s founding principles is “additionality” meaning that the Fund’s investments are added to domestic government and private expenditures but do not replace them.

2.

Global Fund Board approves $229 million in funding for country grants

14 Jan 2019
Three multi-country grants valued at $24 million also approved

On 21 December 2018, the Global Fund Board approved 16 country grants worth $229.4 million. It also approved three multi-country grants valued at $24.0 million. The Board was acting on the recommendations of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC).

5.

Global Fund’s Co-Financing Policy: A primer

3 Apr 2018
The Co-Financing Policy is not always well understood

Pages

Subscribe to co-financing